Delcath Systems, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 2836 www.delcath.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology - Mar 4th, 2026 6:43 am
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology - Mar 3rd, 2026 6:00 am
Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Feb 26th, 2026 2:09 pm
Delcath Systems Q4 Earnings Call Highlights - Feb 26th, 2026 1:48 pm
Delcath (DCTH) Q4 2025 Earnings Call Transcript - Feb 26th, 2026 8:33 am
Delcath Systems, Inc. Q4 2025 Earnings Call Summary - Feb 26th, 2026 6:30 am
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results - Feb 26th, 2026 6:00 am
Does The Market Have A Low Tolerance For Delcath Systems, Inc.'s (NASDAQ:DCTH) Mixed Fundamentals? - Feb 15th, 2026 5:23 am
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call - Feb 12th, 2026 6:00 am
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating - Feb 11th, 2026 1:15 pm
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Jan 27th, 2026 6:05 am
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) - Jan 25th, 2026 5:52 am
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 21st, 2026 2:01 pm
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - Jan 9th, 2026 6:05 am
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Jan 4th, 2026 2:09 pm
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Jan 2nd, 2026 6:38 am
Delcath Systems publishes results from subgroup analyses of FOCUS study - Jan 1st, 2026 6:15 am
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma - Dec 31st, 2025 6:00 am
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Dec 23rd, 2025 10:10 am
Here’s What Hit Delcath Systems (DCTH) in Q3 - Dec 16th, 2025 8:25 am